=====================
Puration , Inc. ( PURA )
Alert Price: $0.06
Price Target: $0.35
(Goldman Small Cap Research)
Float: 537.87M
Website | Recent News
========================
Members,
What if we told you we found a company that analysts believe will double its revenues and more than quadruple its share price?
Sounds almost too good to be true, but that is exactly what analysts are saying about PURA Inc. ( PURA ).
PURA's Growing Distribution Bolsters Analyst $8 Million 2020 Revenue Projection
On Thursday, PURA announced that is growing number of new distribution agreements supports the recent analyst projection for the company to reach $8 million in revenue in 2020. PURA recently announced a new European distribution agreement anticipated to generate $4 million next year with a first shipment scheduled later this month.
Subsequently, PURA announced a new distribution agreement in Latin America. PURA has also announced recent activity that indicates an anticipated increase in sales from Canada resulting from Cannabis 2.0. PURA realized $1 million in revenue last year in 2018 and then reported another $1 million in revenue in just the first six months of 2019. PURA management has set a $4 million revenue target for year end 2019. ,
PURA has had an extremely busy month of October, making several huge announcements which we believe will serve as catalysts for a major bull run in the very near future.
Signs First CBD Beverage Distribution Agreement In Latin America
Management is highlighting the most recent new distribution agreement in Latin America and sharing more details on its potential contribution to PURA’s overall revenue.
The Latin American CBD market is estimated to reach $2 billion by 2026. Goldman Small Cap Research recently reported that the Latin America CBD market is a “burgeoning untapped opportunity.” PURA management is optimistic that the new distribution agreement could add substantial revenue in 2020 and also add revenue in the fourth quarter of 2019.
PURA Launches New CBD Infused Coffee
PURA will begin producing CBD infused Fair Trade coffee from Kenya.
A few months ago, PURA launched an initiative to partner with other beverage companies and introduce CBD Infused beer, coffee and tea beverages. As part of the initiative, PURA engaged Goldman Small Cap Research to conduct a CBD beverage industry survey (see link below).
CBD Beverage Survey Highlights
“Key Numbers: When asked in order of preference what CBD-infused beverage they would buy, 77 or 31% said tea and 74 or 30% said water. As a provider of water and tea, PURA leadership certainly is providing consumers the most popular categories of CBD-infused beverages which bodes very well for future sales and market share growth.”
“The Trend is PURA’s Friend: While CBD oils remain the most popular source of CBD products, the data and responses indicate that oils, vapes, and tinctures usage may be swapped on an ever-increasing scale, for edibles and beverages. We expect that they will eventually overtake these product categories which will be a boon to PURA .”
PURA recently introduced TranquiliTeaCBD as its first new beverage from the beer, coffee and tea initiative. PURA’s new tea is already formulated and ready to go into production. Final packaging design, with the help of shareholder’s feedback on the initial designs, is almost complete. TranquiliTea is expected to be on shelves before the end of the year.
Today, PURA is proud to announce entering into an agreement with a Fair Trade producer of coffee in Kenya. Farmers who grow Fair Trade coffee receive a fair price, and their communities and the environment benefit as well. PURA has engaged Kali-Extracts, Inc. ( KALY ) to design the CBD infusion for ground coffee . PURA anticipates beginning CBD coffee product testing next month. PURA is also in conversations with growers in Ethiopia.
PURA Goldman Small Cap Research Coverage
Goldman Small Cap Research issued an “Alert” follow-up to its recent Research Analyst Report issued on PURA published on September 25th, 2019 (report link below). The Research Analyst Report was triggered by the previously mentioned CBD Beverage Industry Survey conducted on behalf of PURA . The “Alert” is a confirmation of the original investment recommendations and highlights investment new opportunities (alert link below).
To see the full trade alert please follow the link below:
PURATION , Inc. ALERT – October 2, 2019
To see the full Analyst Report please follow the link below:
PURATION , Inc. Research Analyst Report – September 25, 2019
PURA has witnessed growth of 87%, and is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
PURA Will Soon Be Grabbing The Full Attention Of Wall St
PURA Announces Trade Alert Featuring "Rare Entry" Opportunity With "Triple" Potential
Earlier this month, PURA announced a research analyst trade alert highlighting a "rare entry" price opportunity for the shares of PURA and the potential for the share price to triple from current levels.
On September 25th, 2019, Goldman Small Cap Research issued an analyst research report recommending a speculative buy and $0.35 target PPS . Since that time, the PPS has retraced to close yesterday at $0.06. In reaction to the recent trading activity, Goldman today issued a trade alert.
"In recent trading sessions, PURA's stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks."
Two weeks ago, Goldman published the initial results from a CBD Beverage Industry Survey it had conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week.
The Goldman alert today offers commentary on possible explanations for the recent PURA trading activity:
"So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks."
To see the full trade alert follow the link below:
www.goldmanresearch.com/20191002...
About Puration Inc .
PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
For more information on Puration , visit www.purationinc.com
Company Highlights
87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
Announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue.
Sales On Track To Reach $4 Million 2019 Revenue Target
Launched a pre-marketing campaign of its new CBD Infused beer, coffee and tea beverages.
Goldman Small Cap Research Confirms PURA Speculative BUY and $0.35 PPS Target (+400%! Upside From Today's Alert Price)
A first mover in the CBD sports market. Already ahead of CBD giant Aurora Cannabis
Recently announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.
PURA will begin producing CBD infused Fair Trade coffee from Kenya.
EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end. EVERx is now an official sponsor of Jan Tana's Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.
EVERx CBD Sports Water is available for purchase on line at www. USMJ .com hosted by PURA's partner North American Cannabis Holdings, Inc. ( USMJ ).
Bullish Catalysts for PURA
First Shipment of EVERx CBD Sports Water Heads to Europe Next Month
$4 Million 2020 Projection for New Distribution Agreement
PURA New TranquiliTeaCBD Beverage Included in Shipments by Year End
Agreement Supports Analyst Rev Projection and Spec Buy w/$0.35 TGT PPS
Signs First CBD Beverage Distribution Agreement In Latin America
Will begin producing CBD infused Fair Trade coffee from Kenya.
The legalization of cannabis infused edibles and beverages in Canada went into effect October 17th
PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership
PURA management recently disclosed interest expressed in PURA’s EVERx CBD Sports Water in regard to Cannabis 2.0, the legalization of cannabis infused edibles and beverages in Canada which went into effect on October 17th.
Analysts Project $8M in Revenue this Year
Earlier this month, PURA announced the European Distribution Agreement for their EVERx CBD Sports Water and other future CBD infused beverages coming soon. The distributor is a supplier to a grocery chain with approximately 4 Billion Euro in annual sales. The agreement is anticipated to generate one million dollars in sales per quarter in 2020 supporting a recent analyst projection for PURA sales reaching $8 million next year (see more on the $8 million 2020 projection below). The first shipment will go out to the new European Distributor next month and Q4 2019 sales will contribute to refining the 2020 $4 million forecast. PURA expects to add its new TranquiliTeaCBD beverage introduced yesterday to the European Distribution shipments before the end of 2020.
In reaction to shareholder questions regarding the new distribution agreement recently announced, PURA confirmed that the anticipated $4 million from the new distribution agreement is separate from and on top of the existing $4 million, 2019 revenue target.
Source: finance.yahoo.com/news/pura-pura...
PURA 2019 $4 Million Revenue Target On Track And Shareholders Are One Big Step Closer To Receiving Stock Dividend
PURA Reports 87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
PURA Posts $122,000 Net Income From Operations
Sales On Track To Reach $4 Million 2019 Revenue Target
NOUV Issues Preferred Stock To PURA For PURA Shareholder Dividend
In August the Company published a management update in conjunction with the recently published 2019 Q2 Financial Report. The company reported over $1 million in revenue for the first six months of 2019. The 2019 revenue for the first six months of 2019 is 87% higher than the revenue reported for the same period in 2018. The company also posted $122,000 in net income from operations for the first six months of 2019.
CEO Brian Shibley Update:
PURA has announced a $4 million revenue target for 2019. The company broke $1 million in sales for the 2018 fiscal year. I believe the Q2 2019 report demonstrates that the company can reach its $4 million revenue target.
I actually believe sales could have been even higher in the first six months of 2019. We had reached production capacity on our EVERx CBD Sports Water and spent considerable time and effort in the first half of the year overcoming our production constraints. Had we not been constrained, I believe we would have realized more sales in the first two quarters. We simply could not make enough EVERx to satisfy demand. Now the constraints are off and I expect we will see substantial EVERx sales growth in the second half of 2019.
We did get our production capacity under wraps in time to realize the first phase of an order for a private labeled CBD infused water. That gave us a nice boost in sales. However, it also came with an added expense. Both the expense of expanding our production capacity and setting up production for a private labeled product took a toll on our margins. However, that added expense is not recurring and we anticipate improved margins in the following two quarters of this year.
In addition to our revenue growth and the outlook for continued revenue growth and improving margins, PURA also took a big step forward recently on the issuance of the Nouveau, Inc. (NOUV) stock dividend intended for distribution to PURA shareholders. PURA spun-off its cannabis cultivation operation last year to NOUV in a deal that includes a planned distribution of NOUV stock to PURA shareholders. The orchestration of such a dividend issuance is not trivial. It takes some time to get it executed. You will notice on the most recent financial report that NOUV has recently issued preferred stock to PURA . We will in turn distribute the NOUV stock soon to PURA shareholders in a dividend distribution.
Source: finance.yahoo.com/news/pura-pura...
PURA Is A First Mover In The CBD Sports Market. Already Ahead Of Aurora Cannabis
Pura complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market in the United States (US). Aurora Cannabis has just announced plans to pursue the legal hemp derived CBD opportunity in the US focusing first on the sports market where PURA has already made a name for itself. Aurora Cannabis has entered into a clinical research partnership with the UFC (Ultimate Fighting Championship). Aurora Cannabis has voiced its intention on assessing CBD’s potential for treating sports related pain and aiding recovery. PURA has been focused on the sports nutrition market since its introduction of EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival in 2017. EVERx has sponsored multiple MMA (mixed martial arts events) to include sponsoring UFC fighters. EVERx has worked with UFC Fighter Julianna Pena, UFC Fighter Cee Jay Hamilton and two-time Super Bowl quarterback champion Jim McMahon. PURA is the sole licensee of Kali-Extracts ( KALY ) patented cannabis extraction process and has access to KALY’s extensive research on various applications of CBD extracts. PURA has gone global with its marketing of EVERx CBD Sports Water participating in the Arnold Sports Festival worldwide. PURA is launching a European EVERx CBD Sports Water marketing campaign this week at the Arnold Sports Festival in Barcelona, Spain. PURA management views Aurora Cannabis’s US Strategy on target and a validation of PURA’s long-term strategy.
PURA EVERx CBD Sports Water Sales Contribute To USMJ 23% Annual Growth
On Friday, PURA announced that the company’s EVERx CBD Sports Water was a major contributor to North American Cannabis Holdings’, ( USMJ ) recently reported 23% annual growth. USMJ reported $1,059,471 in revenue for its fiscal year end June 30, 2019 compared to $858,175 for the previous year end. The revenue for USMJ increased 23% from 2018 to 2019. USMJ also reported $96,220 in net profit for the year ended 2019. Much of the growth reported by USMJ came from USMJ’s new eCommerce site, www. USMJ .com selling a variety of CBD products and cannabis essentials to include EVERx CBD Sports Water.
PURA Speculative Buy Recommendation and Priced Target Increased to $0.35
Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.35 PPS Target.
Highlights From The Report:
The Bottom Line: In recent trading sessions, PURA’s stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks.
Our Take: Why is the stock down? This question is as old as equity trading itself. We do not purport to have all the answers. However, it has been our experience that oftentimes, certain prices serve as a hurdle for stocks and a catalyst for traders, those taking money off the table, and short sellers. PURA has been under steady pressure since reaching a recent high of $0.099 about ten days ago. That figure was reached shortly after our survey report which quickly turned into a doubling in share price. So, we had a quick rise followed by quick fall. Since we believe that the bulk of trading pressure is largely behind it, a combination of fundamental shifts and potential short covering should drive the stock much higher.
Final Survey Results on Their Way and…The data is great for PURA .—plus there is a surprise along with this release late next week.
So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks.
Today, PURA Trades At a Ridiculous 5x Our Preliminary 2020 EBITDA Estimate. Our target is 30x. That is serious upside potential.
Source: www.goldmanresearch.com/20191002...
Market Outlook:
If possible, the European cannabis legalization environment is more chaotic than in the United States.
Forbes reports: “In the European Union, the legal status of cannabis varies by country. Medical cannabis is legal in Germany, Czech Republic, Italy and Malta. The UK is also moving to legalize medical cannabis. The status of edibles in the EU is legally unclear.”
Nevertheless, the Brightfield Group predicts the EU market for CBD to reach $1.7 billion by 2023.
PURA has specialized in navigating the market dynamics associated with the early market adoption of cannabis products where rules and regulations are not clear and ever changing yet market demand has sent a clear message that consumers are ready for and looking for cannabis products. PURA’s business comes from a spin-off of a cannabis extraction business previously owned by North American Cannabis Holdings, Inc ( USMJ ) which was started in 2013, early on in the cannabis consumer market. PURA management has garnered a wealth of knowledge and experience anticipated to help the company navigate the rapidly growing opportunity in Europe.
In addition to the market experience PURA has gained from its early entry, PURA has also amassed substantial product experience. Not all CBD extracts are created equal and the infusion of CBD into a beverage or edible is not as easy as simply mixing CBD in a mixing bowl. PURA has experienced shelf-life problems, among other issues and in turn, resolved the problems. PURA’s hands on experience and U.S. market presence has made PURA a target of interest of more than one major beverage brand name.
PURA’s EVERx CBD Sports Water and new CBD beverages in the works which will be included in the new distribution agreement, benefit from PURA’s sole license of a U.S. Patented Cannabis Extraction Process for beverage infusion from Kali-Extracts, Inc. ( KALY ). USMJ originally entered into a contract with NCM Biotech, the company that originally owned the Patented Cannabis Extraction Process. USMJ spun the contract off to PURA and NCM Biotech was subsequently acquired by KALY .
US CBD retail sales are expected to grow 133% in 2019 over 2018 reaching over $1 billion and that continued CBD retail sales may exceed $10 billion by 2026.
The Bottom Line
In our opinion, PURA offers more potential upside than any other name in the CBD space.
We ask that you start your research now, and add PURA to the top of your watchlist for tomorrow.
(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards,
*Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report have received compensation from a third party of USD $12,500 cash for a 2-day marketing contract for PURA . Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.
Puration , Inc. ( PURA )
Alert Price: $0.06
Price Target: $0.35
(Goldman Small Cap Research)
Float: 537.87M
Website | Recent News
========================
Members,
What if we told you we found a company that analysts believe will double its revenues and more than quadruple its share price?
Sounds almost too good to be true, but that is exactly what analysts are saying about PURA Inc. ( PURA ).
PURA's Growing Distribution Bolsters Analyst $8 Million 2020 Revenue Projection
On Thursday, PURA announced that is growing number of new distribution agreements supports the recent analyst projection for the company to reach $8 million in revenue in 2020. PURA recently announced a new European distribution agreement anticipated to generate $4 million next year with a first shipment scheduled later this month.
Subsequently, PURA announced a new distribution agreement in Latin America. PURA has also announced recent activity that indicates an anticipated increase in sales from Canada resulting from Cannabis 2.0. PURA realized $1 million in revenue last year in 2018 and then reported another $1 million in revenue in just the first six months of 2019. PURA management has set a $4 million revenue target for year end 2019. ,
PURA has had an extremely busy month of October, making several huge announcements which we believe will serve as catalysts for a major bull run in the very near future.
Signs First CBD Beverage Distribution Agreement In Latin America
Management is highlighting the most recent new distribution agreement in Latin America and sharing more details on its potential contribution to PURA’s overall revenue.
The Latin American CBD market is estimated to reach $2 billion by 2026. Goldman Small Cap Research recently reported that the Latin America CBD market is a “burgeoning untapped opportunity.” PURA management is optimistic that the new distribution agreement could add substantial revenue in 2020 and also add revenue in the fourth quarter of 2019.
PURA Launches New CBD Infused Coffee
PURA will begin producing CBD infused Fair Trade coffee from Kenya.
A few months ago, PURA launched an initiative to partner with other beverage companies and introduce CBD Infused beer, coffee and tea beverages. As part of the initiative, PURA engaged Goldman Small Cap Research to conduct a CBD beverage industry survey (see link below).
CBD Beverage Survey Highlights
“Key Numbers: When asked in order of preference what CBD-infused beverage they would buy, 77 or 31% said tea and 74 or 30% said water. As a provider of water and tea, PURA leadership certainly is providing consumers the most popular categories of CBD-infused beverages which bodes very well for future sales and market share growth.”
“The Trend is PURA’s Friend: While CBD oils remain the most popular source of CBD products, the data and responses indicate that oils, vapes, and tinctures usage may be swapped on an ever-increasing scale, for edibles and beverages. We expect that they will eventually overtake these product categories which will be a boon to PURA .”
PURA recently introduced TranquiliTeaCBD as its first new beverage from the beer, coffee and tea initiative. PURA’s new tea is already formulated and ready to go into production. Final packaging design, with the help of shareholder’s feedback on the initial designs, is almost complete. TranquiliTea is expected to be on shelves before the end of the year.
Today, PURA is proud to announce entering into an agreement with a Fair Trade producer of coffee in Kenya. Farmers who grow Fair Trade coffee receive a fair price, and their communities and the environment benefit as well. PURA has engaged Kali-Extracts, Inc. ( KALY ) to design the CBD infusion for ground coffee . PURA anticipates beginning CBD coffee product testing next month. PURA is also in conversations with growers in Ethiopia.
PURA Goldman Small Cap Research Coverage
Goldman Small Cap Research issued an “Alert” follow-up to its recent Research Analyst Report issued on PURA published on September 25th, 2019 (report link below). The Research Analyst Report was triggered by the previously mentioned CBD Beverage Industry Survey conducted on behalf of PURA . The “Alert” is a confirmation of the original investment recommendations and highlights investment new opportunities (alert link below).
To see the full trade alert please follow the link below:
PURATION , Inc. ALERT – October 2, 2019
To see the full Analyst Report please follow the link below:
PURATION , Inc. Research Analyst Report – September 25, 2019
PURA has witnessed growth of 87%, and is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
PURA Will Soon Be Grabbing The Full Attention Of Wall St
PURA Announces Trade Alert Featuring "Rare Entry" Opportunity With "Triple" Potential
Earlier this month, PURA announced a research analyst trade alert highlighting a "rare entry" price opportunity for the shares of PURA and the potential for the share price to triple from current levels.
On September 25th, 2019, Goldman Small Cap Research issued an analyst research report recommending a speculative buy and $0.35 target PPS . Since that time, the PPS has retraced to close yesterday at $0.06. In reaction to the recent trading activity, Goldman today issued a trade alert.
"In recent trading sessions, PURA's stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks."
Two weeks ago, Goldman published the initial results from a CBD Beverage Industry Survey it had conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week.
The Goldman alert today offers commentary on possible explanations for the recent PURA trading activity:
"So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks."
To see the full trade alert follow the link below:
www.goldmanresearch.com/20191002...
About Puration Inc .
PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
For more information on Puration , visit www.purationinc.com
Company Highlights
87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
Announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue.
Sales On Track To Reach $4 Million 2019 Revenue Target
Launched a pre-marketing campaign of its new CBD Infused beer, coffee and tea beverages.
Goldman Small Cap Research Confirms PURA Speculative BUY and $0.35 PPS Target (+400%! Upside From Today's Alert Price)
A first mover in the CBD sports market. Already ahead of CBD giant Aurora Cannabis
Recently announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.
PURA will begin producing CBD infused Fair Trade coffee from Kenya.
EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end. EVERx is now an official sponsor of Jan Tana's Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.
EVERx CBD Sports Water is available for purchase on line at www. USMJ .com hosted by PURA's partner North American Cannabis Holdings, Inc. ( USMJ ).
Bullish Catalysts for PURA
First Shipment of EVERx CBD Sports Water Heads to Europe Next Month
$4 Million 2020 Projection for New Distribution Agreement
PURA New TranquiliTeaCBD Beverage Included in Shipments by Year End
Agreement Supports Analyst Rev Projection and Spec Buy w/$0.35 TGT PPS
Signs First CBD Beverage Distribution Agreement In Latin America
Will begin producing CBD infused Fair Trade coffee from Kenya.
The legalization of cannabis infused edibles and beverages in Canada went into effect October 17th
PURA Positioned to Take Advantage of Cannabis 2.0 With NOUV Partnership
PURA management recently disclosed interest expressed in PURA’s EVERx CBD Sports Water in regard to Cannabis 2.0, the legalization of cannabis infused edibles and beverages in Canada which went into effect on October 17th.
Analysts Project $8M in Revenue this Year
Earlier this month, PURA announced the European Distribution Agreement for their EVERx CBD Sports Water and other future CBD infused beverages coming soon. The distributor is a supplier to a grocery chain with approximately 4 Billion Euro in annual sales. The agreement is anticipated to generate one million dollars in sales per quarter in 2020 supporting a recent analyst projection for PURA sales reaching $8 million next year (see more on the $8 million 2020 projection below). The first shipment will go out to the new European Distributor next month and Q4 2019 sales will contribute to refining the 2020 $4 million forecast. PURA expects to add its new TranquiliTeaCBD beverage introduced yesterday to the European Distribution shipments before the end of 2020.
In reaction to shareholder questions regarding the new distribution agreement recently announced, PURA confirmed that the anticipated $4 million from the new distribution agreement is separate from and on top of the existing $4 million, 2019 revenue target.
Source: finance.yahoo.com/news/pura-pura...
PURA 2019 $4 Million Revenue Target On Track And Shareholders Are One Big Step Closer To Receiving Stock Dividend
PURA Reports 87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
PURA Posts $122,000 Net Income From Operations
Sales On Track To Reach $4 Million 2019 Revenue Target
NOUV Issues Preferred Stock To PURA For PURA Shareholder Dividend
In August the Company published a management update in conjunction with the recently published 2019 Q2 Financial Report. The company reported over $1 million in revenue for the first six months of 2019. The 2019 revenue for the first six months of 2019 is 87% higher than the revenue reported for the same period in 2018. The company also posted $122,000 in net income from operations for the first six months of 2019.
CEO Brian Shibley Update:
PURA has announced a $4 million revenue target for 2019. The company broke $1 million in sales for the 2018 fiscal year. I believe the Q2 2019 report demonstrates that the company can reach its $4 million revenue target.
I actually believe sales could have been even higher in the first six months of 2019. We had reached production capacity on our EVERx CBD Sports Water and spent considerable time and effort in the first half of the year overcoming our production constraints. Had we not been constrained, I believe we would have realized more sales in the first two quarters. We simply could not make enough EVERx to satisfy demand. Now the constraints are off and I expect we will see substantial EVERx sales growth in the second half of 2019.
We did get our production capacity under wraps in time to realize the first phase of an order for a private labeled CBD infused water. That gave us a nice boost in sales. However, it also came with an added expense. Both the expense of expanding our production capacity and setting up production for a private labeled product took a toll on our margins. However, that added expense is not recurring and we anticipate improved margins in the following two quarters of this year.
In addition to our revenue growth and the outlook for continued revenue growth and improving margins, PURA also took a big step forward recently on the issuance of the Nouveau, Inc. (NOUV) stock dividend intended for distribution to PURA shareholders. PURA spun-off its cannabis cultivation operation last year to NOUV in a deal that includes a planned distribution of NOUV stock to PURA shareholders. The orchestration of such a dividend issuance is not trivial. It takes some time to get it executed. You will notice on the most recent financial report that NOUV has recently issued preferred stock to PURA . We will in turn distribute the NOUV stock soon to PURA shareholders in a dividend distribution.
Source: finance.yahoo.com/news/pura-pura...
PURA Is A First Mover In The CBD Sports Market. Already Ahead Of Aurora Cannabis
Pura complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market in the United States (US). Aurora Cannabis has just announced plans to pursue the legal hemp derived CBD opportunity in the US focusing first on the sports market where PURA has already made a name for itself. Aurora Cannabis has entered into a clinical research partnership with the UFC (Ultimate Fighting Championship). Aurora Cannabis has voiced its intention on assessing CBD’s potential for treating sports related pain and aiding recovery. PURA has been focused on the sports nutrition market since its introduction of EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival in 2017. EVERx has sponsored multiple MMA (mixed martial arts events) to include sponsoring UFC fighters. EVERx has worked with UFC Fighter Julianna Pena, UFC Fighter Cee Jay Hamilton and two-time Super Bowl quarterback champion Jim McMahon. PURA is the sole licensee of Kali-Extracts ( KALY ) patented cannabis extraction process and has access to KALY’s extensive research on various applications of CBD extracts. PURA has gone global with its marketing of EVERx CBD Sports Water participating in the Arnold Sports Festival worldwide. PURA is launching a European EVERx CBD Sports Water marketing campaign this week at the Arnold Sports Festival in Barcelona, Spain. PURA management views Aurora Cannabis’s US Strategy on target and a validation of PURA’s long-term strategy.
PURA EVERx CBD Sports Water Sales Contribute To USMJ 23% Annual Growth
On Friday, PURA announced that the company’s EVERx CBD Sports Water was a major contributor to North American Cannabis Holdings’, ( USMJ ) recently reported 23% annual growth. USMJ reported $1,059,471 in revenue for its fiscal year end June 30, 2019 compared to $858,175 for the previous year end. The revenue for USMJ increased 23% from 2018 to 2019. USMJ also reported $96,220 in net profit for the year ended 2019. Much of the growth reported by USMJ came from USMJ’s new eCommerce site, www. USMJ .com selling a variety of CBD products and cannabis essentials to include EVERx CBD Sports Water.
PURA Speculative Buy Recommendation and Priced Target Increased to $0.35
Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.35 PPS Target.
Highlights From The Report:
The Bottom Line: In recent trading sessions, PURA’s stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks.
Our Take: Why is the stock down? This question is as old as equity trading itself. We do not purport to have all the answers. However, it has been our experience that oftentimes, certain prices serve as a hurdle for stocks and a catalyst for traders, those taking money off the table, and short sellers. PURA has been under steady pressure since reaching a recent high of $0.099 about ten days ago. That figure was reached shortly after our survey report which quickly turned into a doubling in share price. So, we had a quick rise followed by quick fall. Since we believe that the bulk of trading pressure is largely behind it, a combination of fundamental shifts and potential short covering should drive the stock much higher.
Final Survey Results on Their Way and…The data is great for PURA .—plus there is a surprise along with this release late next week.
So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks.
Today, PURA Trades At a Ridiculous 5x Our Preliminary 2020 EBITDA Estimate. Our target is 30x. That is serious upside potential.
Source: www.goldmanresearch.com/20191002...
Market Outlook:
If possible, the European cannabis legalization environment is more chaotic than in the United States.
Forbes reports: “In the European Union, the legal status of cannabis varies by country. Medical cannabis is legal in Germany, Czech Republic, Italy and Malta. The UK is also moving to legalize medical cannabis. The status of edibles in the EU is legally unclear.”
Nevertheless, the Brightfield Group predicts the EU market for CBD to reach $1.7 billion by 2023.
PURA has specialized in navigating the market dynamics associated with the early market adoption of cannabis products where rules and regulations are not clear and ever changing yet market demand has sent a clear message that consumers are ready for and looking for cannabis products. PURA’s business comes from a spin-off of a cannabis extraction business previously owned by North American Cannabis Holdings, Inc ( USMJ ) which was started in 2013, early on in the cannabis consumer market. PURA management has garnered a wealth of knowledge and experience anticipated to help the company navigate the rapidly growing opportunity in Europe.
In addition to the market experience PURA has gained from its early entry, PURA has also amassed substantial product experience. Not all CBD extracts are created equal and the infusion of CBD into a beverage or edible is not as easy as simply mixing CBD in a mixing bowl. PURA has experienced shelf-life problems, among other issues and in turn, resolved the problems. PURA’s hands on experience and U.S. market presence has made PURA a target of interest of more than one major beverage brand name.
PURA’s EVERx CBD Sports Water and new CBD beverages in the works which will be included in the new distribution agreement, benefit from PURA’s sole license of a U.S. Patented Cannabis Extraction Process for beverage infusion from Kali-Extracts, Inc. ( KALY ). USMJ originally entered into a contract with NCM Biotech, the company that originally owned the Patented Cannabis Extraction Process. USMJ spun the contract off to PURA and NCM Biotech was subsequently acquired by KALY .
US CBD retail sales are expected to grow 133% in 2019 over 2018 reaching over $1 billion and that continued CBD retail sales may exceed $10 billion by 2026.
The Bottom Line
In our opinion, PURA offers more potential upside than any other name in the CBD space.
We ask that you start your research now, and add PURA to the top of your watchlist for tomorrow.
(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards,
*Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report have received compensation from a third party of USD $12,500 cash for a 2-day marketing contract for PURA . Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.